C$0.035 AIML.CN AI/ML Innovations Inc. (CNQ) 03 Apr 2026: AI stock to monitor

AIML.CN stock trades at C$0.035 on the CNQ in Canada with heavy intraday activity, volume at 1,409,000 shares versus an average of 401,985, signalling short-term interest. AI/ML Innovations Inc. blends AI and wearables for digital healthcare and shows early-stage revenue, a trailing EPS of -0.03, and a PE of -1.17. Recent reseller news lifted attention but fundamentals show a small market cap of C$5,889,240 and thin liquidity risk. We use a data-driven, AI stocks lens to connect the news, technicals, and Meyka AI model forecasts for a clear trading outlook

AIML.CN stock snapshot and recent news

AI/ML Innovations Inc. (AIML.CN) is quoted at C$0.035 on the CNQ in Canada with a day range of C$0.035–C$0.035 and year range C$0.03–C$0.12. Volume today is 1,409,000, a relative volume of 3.51, which points to outsized intraday interest versus average volume. Recent corporate activity includes a reseller agreement announcement reported on March 31, 2026, that targeted European cardiac monitoring platforms and explains increased trading interest source.

AIML.CN stock financials and valuation

AIML.CN shows early-stage financials with trailing revenue per share C$0.00079, EPS -0.03, and price to sales of 35.00, reflecting a thin revenue base and high valuation multiples for a microcap. Book value per share is C$0.00747 and cash per share is C$0.00532, giving limited balance sheet cushion against execution slip. The company carries modest debt with debt to equity 0.11 but operating cash flow per share is negative at -0.02635, highlighting ongoing cash burn.

AIML.CN stock technicals and trading signals

Technical indicators show muted momentum: RSI 45.06, ADX 17.52 (no clear trend), and MACD flat, which fits a low-price, low-volatility profile. Price averages sit at 50-day C$0.038 and 200-day C$0.044, both above the current C$0.035, indicating the short-term bias is slightly bearish. Bollinger band middle is C$0.04 and on-chain volume metrics show OBV at 400,974, consistent with episodic buying rather than sustained accumulation.

Meyka AI rates AIML.CN with a score out of 100 and forecast

Meyka AI rates AIML.CN with a score out of 100: the proprietary score is 58.47 (Grade C+, suggestion: HOLD). This grade factors in S&P 500 and sector comparisons, financial growth, key metrics, and analyst signals. Meyka AI’s forecast model projects a yearly price of C$0.02174, implying an approximate downside of -37.88% versus the current C$0.035; forecasts are model-based projections and not guarantees. Company rating services also flag caution: an independent rating dated 2026-04-02 lists a D+ and ‘Strong Sell’ recommendation, underlining material execution risk.

AIML.CN stock risks and opportunities in AI healthcare

Opportunity: AIML.CN’s patent-pending personal health monitoring and reseller push into European cardiac platforms could drive commercial milestones and raise revenue traction if validated. Risk: shallow market cap C$5,889,240, negative margins, and stretched liquidity make the stock highly volatile and sensitive to execution news. Regulatory and adoption cycles in medical devices and digital health add timing risk that can widen the stock’s price swings.

AIML.CN stock price targets and analyst context

Given current fundamentals and sector comparisons we outline pragmatic price targets: Bear C$0.02 (down -42.86%), Base C$0.05 (up +42.86%), Bull C$0.12 (up +242.86%) tied to successful product commercialization or large reseller rollouts. There is no formal sell-side consensus or price target published; retail and microcap flows will likely determine short-term moves. For context on market positioning versus peers see the Investing.com company compare note source.

Final Thoughts

AIML.CN stock trades at C$0.035 on the CNQ with active intraday volume of 1,409,000 shares and a market cap of C$5,889,240. The stock sits at a crossroads: corporate news and reseller agreements create short-term upside catalysts, but fundamentals show negative EPS -0.03, negative operating cash flow, and high valuation ratios such as price to sales 35.00, which heighten downside risk. Meyka AI rates AIML.CN C+ (58.47) and its model projects a yearly price of C$0.02174, an implied -37.88% downside versus today; forecasts are model-based projections and not guarantees. For traders focused on AI stocks, AIML.CN offers a high-risk, binary setup where successful commercialization or further reseller wins could lift the base case toward our C$0.05 target, while missed milestones could push the share price toward our bear C$0.02 target. Use position sizing, watch volume and regulators, and consult the Meyka AI platform for live updates and data-driven signals

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.